TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.1.1 MARKET SYNOPSIS
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 LIST OF ASSUMPTIONS
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF MENTAL DISORDERS
4.2.2 RISE IN ADOPTION OF NEW THERAPIES AND TREATMENTS
4.2.3 RISING NUMBER OF STRATEGIC INITIATIVES
4.3 RESTRAINTS
4.3.1 LACK OF AWARENESS AMONG PEOPLE
4.3.2 DEARTH OF QUALIFIED MENTAL HEALTH PROFESSIONALS
4.4 OPPORTUNITIES
4.4.1 INCREASING TECHNOLOGICAL ADVANCEMENT IN REGARD TO MENTAL HEALTH
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 PRODUCT DEVELOPMENT & BUSINESS ACQUISITION (PDBA)
5.1.2 SALES AND MARKETING
5.1.3 CONTRACT MANAGEMENT
5.1.4 CUSTOMER SERVICE & SUPPORT
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL DEPRESSION SCREENING MARKET
5.3.1 IMPACT ON MARKET GROWTH
5.3.2 IMPACT ON VALUE CHAIN
5.3.3 IMPACT ON END USERS
6 GLOBAL DEPRESSION SCREENING MARKET, BY INDICATON
6.1 OVERVIEW
6.2 MAJOR DEPRESSIVE DISORDER
6.3 ANXIETY DISTRESS
6.4 BIPOLAR DISORDER
6.5 PSYCHOTIC DISORDERS
6.6 OTHERS
7 GLOBAL DEPRESION SCREENING MARKET, BY DIAGNOSIS
7.1 OVERVIEW
7.2 PSYCHOLOGICAL TESTS
7.3 BLOOD TESTS
7.4 PHARMACOGENOMIC TESTING
7.5 OTHERS
8 GLOBAL DEPRESSION SCREENING MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS AND CLINICS
8.3 HOME-BASED
8.4 RESEARCH AND ACADEMIC INSTITUTES
9 GLOBAL DEPRESSION SCREENING MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.5 AUSTRALIA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST
9.5.2 AFRICA
9.5.3 LATIN AMERICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL DEPRESSION SCREENING MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL DEPRESSION SCREENING MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL
10.6.2 PARTNERSHIP/AGREEMENT
10.6.3 MERGER /ACQUISTION
10.7 FINANCIAL MATRIX
10.7.1 SALES (USD BILLION), 2022
10.7.2 R&D EXPENDITURE (USD BILLION), 2022
11 COMPANY PROFILES
11.1 NATIONAL PSYCHOLOGICAL CORPORATION
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIES
11.2 BRUKER
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 MEDTRONIC
11.3.1 COMPANY OVERVIEWS
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 MULTI-HEALTH SYSTEMS INC.
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 NEDLEY HEALTH
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 DANAHER CORPORATION
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 PEARSON
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS/SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 SIGMA ASSESSMENT SYSTEMS INC.
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 SIEMENS
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 PAR, INC.
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
11.11 MYRIAD GENETICS, INC.
11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL OVERVIEW
11.11.3 PRODUCTS OFFERED
11.11.4 KEY DEVELOPMENTS
11.11.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 GLOBAL DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 3 GLOBAL DEPRESSION SCREENING MARKET, FOR MAJOR DEPRESSIVE DISORDER, BY REGION, 2019–2032 (USD BILLION)
TABLE 4 GLOBAL DEPRESSION SCREENING MARKET, FOR ANXIETY DISTRESS, BY REGION, 2019–2032 (USD BILLION)
TABLE 5 GLOBAL DEPRESSION SCREENING MARKET, FOR BIPOLAR DISORDER, BY REGION, 2019–2032 (USD BILLION)
TABLE 6 GLOBAL DEPRESSION SCREENING MARKET, FOR PSYCHOTIC DISORDERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 7 GLOBAL DEPRESSION SCREENING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 8 GLOBAL DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 9 GLOBAL DEPRESSION SCREENING MARKET, FOR PSYCHOLOGICAL TESTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 10 GLOBAL DEPRESSION SCREENING MARKET, FOR BLOOD TESTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 11 GLOBAL DEPRESSION SCREENING MARKET, FOR PHARMACOGENOMIC TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 12 GLOBAL DEPRESSION SCREENING MARKET, FOR OTHERS, BY ERGION, 2019–2032 (USD BILLION)
TABLE 13 GLOBAL DEPRESSION SCREENING MARKET, FOR END USER, BY REGION, 2019–2032 (USD BILLION)
TABLE 14 GLOBAL DEPRESSION SCREENING MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2019–2032 (USD BILLION)
TABLE 15 GLOBAL DEPRESSION SCREENING MARKET, FOR HOME-BASED, BY REGION, 2019–2032 (USD BILLION)
TABLE 16 GLOBAL DEPRESSION SCREENING MARKET, FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2019–2032 (USD BILLION)
TABLE 17 GLOBAL: DEPRESSION SCREENING MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 18 NORTH AMERICA: DEPRESSION SCREENING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 19 NORTH AMERICA: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 20 NORTH AMERICA: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 21 NORTH AMERICA: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 22 US: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 23 US: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 24 US: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 25 CANADA: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 26 CANADA: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 27 CANADA: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 28 EUROPE: DEPRESSION SCREENING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 29 EUROPE: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 30 EUROPE: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 31 EUROPE: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 32 GERMANY: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 33 GERMANY: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 34 GERMANY: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 35 UK: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 36 UK: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 37 UK: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 38 FRANCE: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 39 FRANCE: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 40 FRANCE: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 41 ITALY: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 42 ITALY: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 43 ITALY: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 44 SPAIN: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 45 SPAIN: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 46 SPAIN: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 47 REST OF EUROPE: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 48 REST OF EUROPE: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 49 REST OF EUROPE: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 50 ASIA-PACIFIC: DEPRESSION SCREENING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 51 ASIA-PACIFIC: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 52 ASIA-PACIFIC: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 53 ASIA-PACIFIC: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 54 JAPAN: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 55 JAPAN: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 56 JAPAN: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 57 CHINA: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 58 CHINA: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 59 CHINA: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 60 INDIA: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 61 INDIA: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 62 INDIA: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 63 SOUTH KOREA: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 64 SOUTH KOREA: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 65 SOUTH KOREA: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 66 AUSTRALIA: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 67 AUSTRALIA: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 68 AUSTRALIA: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 69 REST OF ASIA-PACIFIC: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 70 REST OF ASIA-PACIFIC: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 71 REST OF ASIA-PACIFIC: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 72 REST OF THE WORLD: DEPRESSION SCREENING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 73 REST OF THE WORLD: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 74 REST OF THE WORLD: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 75 REST OF THE WORLD: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 76 MIDDLE EAST: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 77 MIDDLE EAST: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 78 MIDDLE EAST: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 79 AFRICA: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 80 AFRICA: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 81 AFRICA: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 82 LATIN AMERICA: DEPRESSION SCREENING MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 83 LATIN AMERICA: DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2019–2032 (USD BILLION)
TABLE 84 LATIN AMERICA: DEPRESSION SCREENING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 85 MAJOR PLAYERS IN THE GLOBAL DEPRESSION SCREENING MARKET
TABLE 86 MOST ACTIVE PLAYER IN THE GLOBAL DEPRESSION SCREENING MARKET
TABLE 87 PRODUCT LAUNCH/ PRODUCT APPROVAL
TABLE 88 PARTNERSHIP/AGREEMENT
TABLE 89 MERGER/ACQUISTION
TABLE 90 NATIONAL PSYCHOLOGICAL CORPORATION.: PRODUCTS OFFERED
TABLE 91 BRUKER: PRODUCTS OFFERED
TABLE 92 BRUKER: KEY DEVELOPMENTS
TABLE 93 MEDTRONIC: PRODUCTS OFFERED
TABLE 94 MEDTRONIC: KEY DEVELOPMENTS
TABLE 95 MULTI-HEALTH SYSTEMS INC.: PRODUCTS OFFERED
TABLE 96 NEDLEY HEALTH: PRODUCTS OFFERED
TABLE 97 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 98 DANAHER CORPORATION: KEY DEVELOPMENTS
TABLE 99 PEARSON: PRODUCTS/SERVICES OFFERED
TABLE 100 SIGMA ASSESSMENT SYSTEMS INC.: PRODUCTS/SERVICES OFFERED
TABLE 101 SIEMENS: PRODUCTS OFFERED
TABLE 102 SIEMENS: KEY DEVELOPMENTS
TABLE 103 PAR, INC.: PRODUCTS/SERVICES OFFERED
TABLE 104 MYRIAD GENETICS, INC.: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL DEPRESSION SCREENING MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: GLOBAL DEPRESSION SCREENING MARKET
FIGURE 4 DRIVER IMPACT ANALYSIS
FIGURE 5 RESTRAINT IMPACT ANALYSIS
FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL DEPRESSION SCREENING MARKET
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DEPRESSION SCREENING MARKET
FIGURE 8 GLOBAL DEPRESSION SCREENING MARKET SHARE (%), BY INDICATION, 2022
FIGURE 9 GLOBAL DEPRESSION SCREENING MARKET, BY INDICATION (USD BILLION)
FIGURE 10 GLOBAL DEPRESSION SCREENING MARKET SHARE (%), BY DIAGNOSIS, 2022
FIGURE 11 GLOBAL DEPRESSION SCREENING MARKET, BY DIAGNOSIS (USD BILLION)
FIGURE 12 GLOBAL DEPRESSION SCREENING MARKET SHARE (%), BY END USER, 2022
FIGURE 13 GLOBAL DEPRESSION SCREENING MARKET, BY END USER (USD BILLION)
FIGURE 14 GLOBAL: DEPRESSION SCREENING MARKET SHARE (%), BY REGION, 2022
FIGURE 15 GLOBAL: DEPRESSION SCREENING MARKET, BY REGION, 2022 & 2030 (USD BILLION)
FIGURE 16 NORTH AMERICA: DEPRESSION SCREENING MARKET SHARE (%), BY COUNTRY 2022
FIGURE 17 EUROPE: DEPRESSION SCREENING MARKET SHARE (%), BY COUNTRY 2022
FIGURE 18 ASIA-PACIFIC: DEPRESSION SCREENING MARKET SHARE (%), BY REGION, 2022
FIGURE 19 REST OF THE WORLD: DEPRESSION SCREENING MARKET SHARE (%), BY REGION, 2022
FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL DEPRESSION SCREENING MARKET
FIGURE 22 GLOBAL DEPRESSION SCREENING MARKET: COMPETITIVE LANDSCAPE
FIGURE 23 SALES, 2022
FIGURE 24 R&D EXPENDITURE, 2022
FIGURE 25 BRUKER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 BRUKER: SWOT ANALYSIS
FIGURE 27 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 MEDTRONIC: SWOT ANALYSIS
FIGURE 29 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 DANAHER CORPORATION: SWOT ANALYSIS
FIGURE 31 PEARSON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 PEARSON: SWOT ANALYSIS
FIGURE 33 SIEMENS: FINANCIAL OVERVIEW
FIGURE 34 SIEMENS: SWOT ANALYSIS
FIGURE 35 MYRIAD GENETICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
